Cargando…
C-peptide and Central Nervous System Complications in Diabetes
Substantial evidence collected from clinical data and experimental studies has indicated that CNS is not spared from diabetes complications. Impairments in CNS function are well documented in both type 1 and type 2 diabetic patients as well as in various animal models of diabetes, in terms of altera...
Autores principales: | Li, Zhen-guo, Sima, Anders A. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478617/ https://www.ncbi.nlm.nih.gov/pubmed/15198373 http://dx.doi.org/10.1080/15438600490424550 |
Ejemplares similares
-
C-Peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes
por: Li, Zhen-guo, et al.
Publicado: (2002) -
The Insulin-Like Growth Factor System and Neurological Complications in Diabetes
por: Sima, Anders A. F., et al.
Publicado: (2003) -
The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy
in the BB/Wor-rat
por: Sima, Anders A. F., et al.
Publicado: (2008) -
Type 1 Diabetic Neuropathy and C-peptide
por: Sima, Anders A. F., et al.
Publicado: (2004) -
Simultaneous central nervous system complications of C. neoformans infection
por: González-Duarte, Alejandra, et al.
Publicado: (2009)